The Clinical Characteristics and Prognostic Factors of Primary Extramammary Paget’s Disease Treated with Surgery in Anogenital Regions: A Large Population Study from the SEER Database and Our Centre

Zeyang Chen, Zining Liu, Shaorong Pan, Jin Liu, Shuai Zuo, Pengyuan WangJournal of Clinical Medicine 2023 · DOI

TL;DR

This study investigates the clinical characteristics and prognostic factors of primary Extramammary Paget's Disease (EMPD) in the anogenital region, a rare and often misdiagnosed cancer. By analyzing data from the SEER database and a single institution, the researchers identified key risk factors for patient survival and disease recurrence, aiming to improve diagnosis and treatment strategies for this challenging condition.

What Problem Does This Paper Address?

Extramammary Paget's Disease (EMPD) is a rare malignant tumor that primarily affects areas rich in apocrine glands, with the anogenital region being the most common site. A significant challenge in managing EMPD is its delayed diagnosis, as its symptoms (rash, itching, erosion) are often mistaken for benign inflammatory or infectious conditions. This delay, coupled with the complexity of surgical treatment in the anogenital area (where preserving function is crucial), leads to treatment difficulties and can impact patient prognosis. Currently, there's a lack of comprehensive research specifically focusing on the clinicopathological characteristics and prognostic factors of EMPD in these critical regions. This paper aims to fill that gap by providing a large-scale analysis to inform better diagnostic and therapeutic approaches.

Methods

The study employed a two-pronged approach:

  1. SEER Database Analysis: Data from 688 patients diagnosed with primary EMPD in anogenital regions between 1992 and 2021 were extracted from the Surveillance, Epidemiology, and End Results (SEER) program. This provided a large, population-based dataset for initial analysis.
  2. Single-Center Cohort Study: An additional 176 patients who underwent surgery for primary EMPD in anogenital regions at Peking University First Hospital between 2011 and 2021 were included. This allowed for a more detailed investigation of specific clinicopathological data and follow-up information.

Statistical analyses included Kaplan-Meier methods for survival analysis and Cox proportional hazards models (using a backward stepwise regression method) to identify independent risk factors for cancer-specific survival (CSS) and progression-free survival (PFS).

Datasets

  • SEER Database: A comprehensive cancer registry covering approximately 30% of the US population, providing data on incidence and mortality. The study utilized data from 1992-2021, focusing on patients with histologically confirmed extramammary Paget's disease in anogenital regions who underwent surgery.
  • Peking University First Hospital Cohort: A dataset of 176 patients treated at the institution from 2011-2021, providing more granular clinical and pathological details, including invasion depth, lymph node status, and recurrence data.

Key Insights and Ideas

  • Anogenital EMPD is Often Misdiagnosed: The paper reiterates that the non-specific symptoms of EMPD in the anogenital region lead to significant diagnostic delays, often exceeding two years. This highlights the need for increased physician awareness.
  • Demographic Differences Matter: While the SEER data showed a higher prevalence in females and specific ethnic groups (Spanish-Hispanic-Latino), the single-center data revealed a male predominance, potentially due to referral bias from specialized urology/andrology departments.
  • Tumor Characteristics are Crucial Prognosticators: The study strongly emphasizes that factors like lymph node metastasis and tumor invasion depth are critical indicators of poor prognosis, regardless of the data source.
  • Site-Specific Prognosis: Lesions in the anal region were identified as a significant risk factor for poor prognosis in the SEER data, likely due to anatomical challenges and potential for early spread.
  • Treatment Modalities and Outcomes: While surgical excision is the primary treatment, the study hints at the potential benefits of minimally invasive techniques like Mohs micrographic surgery (MMS) for better outcomes, though more research is needed.

Key Results

From the SEER Program Data:

  • Independent Risk Factors for Shorter Cancer-Specific Survival (CSS):
    • Age ≥ 65 years (HR = 8.51)
    • Lymph node metastasis (HR = 214.24)
    • Spanish-Hispanic-Latino ethnicity (HR = 13.44)
    • Lesion diameter > 10 cm (HR = 14.35)
    • Anal location (HR = 115.38)

From the Centre Cohort Data:

  • Independent Risk Factors for Shorter Progression-Free Survival (PFS) and CSS:
    • Lymph node metastasis (HR = 10.33 for PFS and CSS)
    • Tumor extending through the epidermis (invasion depth) (HR = 2.96 for PFS and CSS)

Limitations and Future Work

  • Retrospective Nature: Both datasets are retrospective, which inherently limits the ability to establish causality and may be subject to selection bias.
  • Data Discrepancies: The SEER database and the center's data had differing variables, making direct comparison and model validation challenging.
  • Limited Information: The SEER data lacked detailed information on radiation fields, chemotherapy agents, and specific margin distances.
  • Reconstruction Method: The study found that reconstruction with free skin flaps was associated with shorter PFS and CSS in the center cohort, which is counterintuitive. The authors suggest this might be due to scar tissue masking early recurrence or detection issues, recommending further investigation and more frequent follow-ups for patients undergoing such reconstruction.
  • TNM Staging: The lack of a universally accepted TNM staging system for EMPD remains a challenge.
  • Future Directions: The authors suggest further research into the pathogenesis of EMPD to identify new therapeutic targets. They also highlight the potential of minimally invasive techniques like MMS and sentinel lymph node (SLN) biopsy for improved management and functional outcomes. More extensive research is needed to optimize treatment strategies and establish more reasonable follow-up protocols.

Summary updated

Abstract

Background: Extramammary Paget’s disease (EMPD) is a rare malignant cutaneous tumour that is commonly located in anogenital regions. The diagnosis of the disease is always delayed, and treatment is usually troublesome. This study aims to summarise the clinicopathological characteristics and the risk factors of prognosis for EMPD in anogenital regions, potentially providing evidence for the diagnosis and treatment of anogenital EMPD. Methods: 688 patients were sourced from the Surveillance, Epidemiology and End Results (SEER) program between 1992 and 2021. In total, 176 participants from our centre from between 2011 and 2021 were included to investigate the characteristics and prognosis for EMPD in anogenital regions. Results: From the SEER program data, patient age of 65 years or older, metastasis of lymph nodes, Spanish-Hispanic-Latino race, diameter exceeding 10cm and lesions located anally were revealed as independent risk factors for shorter cancer-specific survival (CSS). However, the data from our centre highlighted that metastasis of lymph nodes and tumours extending through the epidermis are independent risk factors of shortened progression-free survival (PFS) and CSS of anogenital EMPD. Conclusion: This synthesised study revealed that some characteristics are regarded as risk factors for poor clinical prognosis, which have potential value in formulating more normative and effective strategies for patients with EMPD in anogenital regions.
BibTeX
@article{chen2023clinical,
  author = {Zeyang Chen and Zining Liu and Shaorong Pan and Jin Liu and Shuai Zuo and Pengyuan Wang},
  title = {{The Clinical Characteristics and Prognostic Factors of Primary Extramammary Paget’s Disease Treated with Surgery in Anogenital Regions: A Large Population Study from the SEER Database and Our Centre}},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  doi = {10.3390/jcm12020582},
}
Figure